ÂÜÀòÂÒÂ×

The Leadership Team at Reneo Pharmaceuticals is responsible for guiding the company’s strategic vision and operational execution in the development of therapies for genetic mitochondrial diseases. Comprising key executives including the Chief Medical Officer, Chief Development Officer, President & CEO, and Chief Business Officer, the team collaborates to advance clinical programs, secure funding, and foster partnerships that enhance Reneo's growth and innovation in the pharmaceutical sector.